Achilles Therapeutics plc (ACHL)

NASDAQ: ACHL · IEX Real-Time Price · USD
2.52
0.11 (4.56%)
At close: May 20, 2022 4:00 PM
2.51
-0.01 (-0.40%)
After-hours:May 20, 2022 5:27 PM EDT

Income Statement (Annual)

Millions USD. Fiscal year is Jan - Dec.
Year202120202019
Selling, General & Admin
21.9711.14.7
Research & Development
42.2222.639.07
Operating Expenses
64.233.7313.78
Operating Income
-64.2-33.73-13.78
Other Expense / Income
-3.13-0.530.22
Pretax Income
-61.06-33.2-13.99
Income Tax
0.0400
Net Income
-61.1-33.2-13.99
Net Income Common
-61.1-33.2-13.99
Shares Outstanding (Basic)
2911
Shares Outstanding (Diluted)
2911
Shares Change
2587.54%66.03%-
EPS (Basic)
-2.13-31.14-21.79
EPS (Diluted)
-2.13-31.14-21.79
Free Cash Flow Per Share
-2.33-34.80-23.49
Effective Tax Rate
-0.06%-0.01%0.00%
EBITDA
-57.77-32.42-13.69
EBIT
-61.06-33.2-13.99
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).